Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: The Zhejiang Zhenhai study

American Journal of Gastroenterology

Volumn 108, Issue 8, 2013, Pages 1299-1304

  Xu, Chengfu ^a   Yu, Chaohui ^a   Ma, Han ^a   Xu, Lei ^a,b   Miao, Min ^c   Li, Youming ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b NINGBO FIRST HOSPITAL   (China)

^c Zhenhai Lianhua Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOCYTE COUNT; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; CHINA; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84881147421     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.104     Document Type: Article

References (31)

1. Williams CD, Stengel J, Asike MI et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124-31.
2. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Th er 2011;34:274-85.
3. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009;50:204-10.
4. Chitturi S, Wong VW, Farrell G. Nonalcoholic fatty liver in Asia: fi rmly entrenched and rapidly gaining ground. J Gastroenterol Hepatol 2011;26 (Suppl 1):163-72.
5. Matteoni CA, Younossi ZM, Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9.
6. Bugianesi E, Leone N, Vanni E et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-40.
7. Chalasani N, Younossi Z, Lavine JE et al. Th e diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-23.
8. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341-50.
9. Sung KC, Kim SH. Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes. J Clin Endocrinol Metab 2011;96:1093-7.
10. Targher G, Bertolini L, Rodella S et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 2008;51:444-50.
11. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010;51:679-89.
12. Chen CH, Huang MH, Yang JC et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic signifi cance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 2006;40:745-52.
13. Kim HJ, Kim HJ, Lee KE et al. Metabolic signifi cance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med 2004;164:2169-75.
14. Das K, Das K, Mukherjee PS et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and signifi cant liver disease. Hepatology 2010;51:1593-602.
15. Li Y, Xu C, Yu C et al. Association of serum uric acid level with nonalcoholic fatty liver disease: a cross-sectional study. J Hepatol 2009 ; 50:1029-34.
16. Yu C, Xu C, Xu L et al. Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease. J Hepatol 2012;56:241-7.
17. Hamaguchi M, Kojima T, Takeda N et al. Th e metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005;143:722-8.
18. Cerda C, Perez-Ayuso RM, Riquelme A et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol 2007;47:412-7.
19. Zeng MD, Fan JG, Lu LG et al. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis 2008;9:108-12.
20. Fan JG, Saibara T, Chitturi S et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacifi c? J Gastroenterol Hepatol 2007;22:794-800.
21. Liu CJ. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol 2012;27:1555-60.
22. Kim HK, Park JY, Lee KU et al. Eff ect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans. Am J Med Sci 2009;337:98-102.
23. Wong VW, Wong GL, Choi PC et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010;59:969-74.
24. Stocker R, Yamamoto Y, McDonagh AF et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043-6.
25. Sedlak TW, Saleh M, Higginson DS et al. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci USA 2009;106:5171-6.
26. Lin YC, Chang PF, Hu FC et al. Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease. Pediatrics 2009;124:e1221-7.
27. Chang Y, Ryu S, Zhang Y et al. A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers. PLoS One 2012;7:e37241.
28. Xu L, Xu CF, Yu CH et al. Haemoglobin and non-alcoholic fatty liver disease: further evidence from a population-based study. Gut 2009;58:1706-7.
29. Yoneda M, Fujii H, Sumida Y et al. Platelet count for predicting fi brosis in nonalcoholic fatty liver disease. J Gastroenterol 2011;46:1300-6.
30. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31.
31. Sinn DH, Gwak GY, Park HN et al. Ultrasonographically detected nonalcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. Am J Gastroenterol 2012;107:561-7.